Lotrimin AF Deodorant Powder Spray Recalled for Benzene Contamination
Bayer Healthcare is recalling Lotrimin AF Deodorant Powder Spray (Miconazole nitrate 2%) nationwide due to the presence of benzene contamination. The recall affects approximately 2.8 million cans distributed across the US, Puerto Rico, Canada, and Mexico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This recall is classified as FDA Class I by the agency, which mandates a minimum severity score of 4 per the rubric. Benzene is a known human carcinogen and volatile chemical contaminant that poses a serious health risk through inhalation exposure from a powder spray product.
Plain-English summary
Bayer Healthcare Pharmaceuticals Inc. is recalling Lotrimin AF Deodorant Powder Spray (Miconazole nitrate 2%), 133g (4.6 oz) cans, due to chemical contamination involving the presence of benzene.
The affected product was distributed nationwide in the US, Puerto Rico, Canada, and Mexico through various retail channels. The recall involves approximately 2,817,468 cans with lot numbers TN008D3 and TN009K7, with an expiration date of 5/31/2023 (NDC 11523-1272-2; UPC 3 11017 41023 3).
Consumers who have purchased this product should stop using it immediately. Consumers with questions or concerns should contact Bayer Healthcare LLC at their customer service line. Healthcare providers and pharmacies should quarantine remaining stock and arrange for returns.
The recalled product
- Product
- LOTRIMIN AF (Miconazole nitrate 2%) Deodorant Powder Spray, NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-1272-2 UPC 3 11017 41023 3
- Manufacturer
- Bayer Healthcare Pharmaceuticals Inc.
- Category
- Drug — Topical Antifungal
- Hazard
- benzene-contamination
- chemical-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot # TN008D3
- TN009K7
- Exp 5/31/2023.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27